| scholarly article | Q13442814 |
| P50 | author | Paweł Górski | Q19690546 |
| Karolina H Czarnecka | Q57063857 | ||
| Jacek Kordiak | Q59681616 | ||
| Dorota Pastuszak-Lewandoska | Q60396877 | ||
| Adam Antczak | Q84358758 | ||
| P2093 | author name string | Daria Domańska | |
| Ewa Nawrot | |||
| Monika Migdalska-Sęk | |||
| Ewa Brzeziańska | |||
| P2860 | cites work | Cancer statistics, 2013 | Q27860762 |
| The B7 family revisited | Q28240070 | ||
| Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis | Q28302483 | ||
| Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population | Q33297928 | ||
| Association between the Cytotoxic T-Lymphocyte Antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis | Q33710123 | ||
| Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians | Q34150405 | ||
| CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer. | Q34630161 | ||
| CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis | Q34631546 | ||
| CTLA-4: new insights into its biological function and use in tumor immunotherapy | Q34711491 | ||
| CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors | Q35101747 | ||
| Natural T cell immunity against cancer. | Q35557820 | ||
| CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves' disease and Hashimoto's thyroiditis). | Q36105659 | ||
| Immune microenvironment in tumor progression: characteristics and challenges for therapy | Q36178400 | ||
| Signaling defects in anti-tumor T cells | Q37063739 | ||
| Targeting costimulatory molecules to improve antitumor immunity. | Q38002404 | ||
| T-regulatory cells: key players in tumor immune escape and angiogenesis | Q38006901 | ||
| CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction | Q40418115 | ||
| CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease | Q40841269 | ||
| CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms | Q43653596 | ||
| Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease | Q43774149 | ||
| Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism is associated with increased risk of osteosarcoma | Q44842099 | ||
| Cytotoxic T lymphocyte antigen-4 gene in breast cancer | Q44952284 | ||
| Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma | Q46879549 | ||
| Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block | Q56903189 | ||
| A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele | Q56904151 | ||
| A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein | Q56904398 | ||
| Study of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer | Q57904713 | ||
| T-cell costimulation--biology, therapeutic potential, and challenges | Q80111065 | ||
| Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study. | Q50574501 | ||
| Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. | Q53318054 | ||
| CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. | Q53336075 | ||
| Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer. | Q53667526 | ||
| CTLA4 gene variations and haplotypes in patients with lung cancer. | Q54445924 | ||
| CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese. | Q54463319 | ||
| Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. | Q54521538 | ||
| [Expression and significance of gp96 and immune-related gene CTLA-4, CD8 in lung cancer tissues]. | Q55426642 | ||
| Association of cytotoxic T-lymphocyte associated antigen 4 gene polymorphism with type 1 diabetes mellitus: a meta-analysis | Q56897823 | ||
| Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis | Q56898076 | ||
| Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis | Q56898637 | ||
| New insights of CTLA-4 into its biological function in breast cancer | Q56899301 | ||
| Association of CT60 cytotoxic T lymphocyte antigen-4 gene polymorphism with thyroid autoantibody production in patients with Hashimoto's and postpartum thyroiditis | Q56899519 | ||
| Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population | Q56899729 | ||
| Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population | Q56900757 | ||
| CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers | Q56900986 | ||
| CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis | Q56902905 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 576486 | |
| P577 | publication date | 2013-07-09 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer | |
| P478 | volume | 2013 |
| Q36464841 | Association between CTLA-4 rs231775 polymorphism and hepatocellular carcinoma susceptibility |
| Q42683596 | CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases |
| Q39748066 | CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor. |
| Q90352713 | CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis |
| Q36046801 | Cytotoxic T lymphocyte-associated antigen-4 +49A>G polymorphism and the risk of non-small cell lung cancer in a Chinese population |
| Q38785402 | Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion |
| Q38733611 | ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer. |
| Q38549542 | Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights |
| Q43278116 | Investigation of Cytotoxic T-lymphocyte antigen-4 polymorphisms in non-small cell lung cancer: a case-control study |
| Q39515498 | Lack of association between cytotoxic T-lymphocyte antigen-4 gene polymorphisms and lymphoid malignancy risk: evidence from a meta-analysis |
| Q37309882 | Molecular Imaging of Immunotherapy Targets in Cancer |
| Q36318092 | Polymorphisms of co-inhibitory molecules (CTLA-4/PD-1/PD-L1) and the risk of non-small cell lung cancer in a Chinese population |
| Q33688783 | Role of CD152 genetic polymorphisms in the susceptibility to breast cancer |
| Q34161679 | The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis |
| Q58096039 | Tumour cell-intrinsic CTLA4 regulates PD-L1 expression in non-small cell lung cancer |
Search more.